Investor Relations
Key Figures
| IFRS (in EURm except otherwise stated) | 2018 | 2017 |
| Revenues | 3,781.1 | 2,971.4 |
| Adjusted EBITDA | 719.8 | 556.7 |
| Reported EBITDA | 651.4 | 513.2 |
| Adjusted Basic EPS (EUR) | 20.11 | 17.49 |
| Net Operating Cash Flow | 543.9 | 405.1 |
Outstanding shares:
17,792,600 (at 31.07.2019)
Dividend
The AGM of 25 April 2019 approved the payment of a dividend of EUR 2.88 per share for the year 2018 compared to EUR 2.40 for the previous year.
Financial News
- 25.06.2019Eurofins Expands its Transplantation Testing Footprint with the Acquisition of Transplant Genomics Inc.
- 24.06.2019Operations returning to normal after the cyber attack announced on June 3, 2019
- 10.06.2019Update on the cyber-attack announced on June 3, 2019
- 03.06.2019Eurofins Scientific ad hoc press release
- 26.04.2019Eurofins revenues grow 27% in Q1 2019 to EUR 1,067m
Annual Reports
Next Publication: HY 2019 Results Publication, 29 August 2019
Sign up to Eurofins' IR distribution list
Eurofins' 20-year IPO value creation study by Marten & Co.
Research Paper by Prof. Brooks
OBSAAR prospectus in French only